Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)


Asthma prevalence in Italy is on the rise and is estimated to be over 6% of the general population. The diagnosis of asthma can be challenging and elusive, especially in children and the last two decades has brought evidences that asthma is not a single disease but consists of various phenotypes. Symptoms can be underestimated by the patient or underreported to the clinician and physical signs can be scanty. Usual objective measures, like spirometry, are necessary but sometimes not significant. Despite proper treatment asthma can be a very severe condition (even leading to death) however new drugs have recently become available which can be very effective in its control. Since asthma is currently thought to be caused by inflammation, a direct measure of the latter can be of paramount importance.  For this purpose, the measurement of Fractional Exhaled Nitric Oxide (FENO) has been used since the early years of the current century as a non-invasive, easy-to-assess tool useful for diagnosing and managing asthma. This SIP-IRS/SIAAIC Position Paper is a narrative review which summarizes the evidence behind the usefulness of FENO in the diagnosis, management and phenotypization of asthma.



PlumX Metrics


Download data is not yet available.


Global Initiative for Asthma. Accessed on: 4th July 2019. Available at:

Cazzola M, Puxeddu, E, Bettoncelli, G, Novelli L; Segreti A, Cricelli C, et al. The prevalence of asthma and COPD in Italy: A practice-based study. Respir Med 2011;105:386-91. DOI:

de Marco R, Cappa V, Accordini S, Rava M, Antonicelli L, Bortolami O, et al. Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J 2012;39:883-92. DOI:

Baiardini I, Novakova S, Mihaicuta S, Oguzulgen IK, Canonica GW. Adherence to treatment in allergic respiratory diseases. Expert Rev Respir Med 2019;13:53-62. DOI:

Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014;43:343-73. DOI:

Senna G, Guerriero M, Paggiaro PL, Blasi F, Caminati M, Heffler E, et al. SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma. Clin Mol Allergy 2017;15:9. DOI:

Heffler E, Blasi F, Latorre M, Menzella F, Paggiaro P, Pelaia G, et al. The Severe Asthma Network in Italy: Findings and perspectives. J Allergy Clin Immunol Pract 2019;7:1462-8. DOI:

Kuruvilla ME, Lee FE, Lee GB. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol 2019;56:219-33. DOI:

Robinson D, Humbert M, Buhl R, Cruz AA, Inoue H, Korom S, et al. Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy 2017;47:161-75. DOI:

Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006;11:54-61. DOI:

Canonica GW, Ferrando M, Baiardini I, Puggioni F, Racca F, Passalacqua G, et al. Asthma: personalized and precision medicine. Curr Opin Allergy Clin Immunol 2018;18:51-8. DOI:

Corren J. New targeted therapies for uncontrolled asthma. J Allergy Clin Immunol Pract 2019;7:1394-403. DOI:

Woo SI, Lee JH, Kim H, Kang JW, Sun YH, Hahn YS. Utility of fractional exhaled nitric oxide (FENO) measurements in diagnosing asthma. Respir Med 2012;106:1103-9. DOI:

LaForce C, Brooks E, Herje N, Dorinsky P, Rickard K. Impact of exhaled nitric oxide measurements on treatment decisions in an asthma specialty clinic. Ann Allergy Asthma Immunol 2014;113:619-23. DOI:

McCleverty JA. Chemistry of nitric oxide relevant to biology. Chem Rev 2004;104:403-18. DOI:

Ford PC, Wink DA, Stanbury DM. Autoxidation kinetics of aqueous nitric oxide. FEBS Lett 1993;326:1-3. DOI:

Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271:C1424-37. DOI:

Kelm M, Feelisch M, Krebber T, Deussen A, Motz W, Strauer BE. Role of nitric oxide in the regulation of coronary vascular tone in hearts from hypertensive rats. Maintenance of nitric oxide-forming capacity and increased basal production of nitric oxide. Hypertension 1995;25:186-93. DOI:

Maniscalco M, Sofia M, Pelaia G. Nitric oxide in upper airways inflammatory diseases. Inflamm Res 2007;56:58-69. DOI:

Lundberg JO, Weitzberg E, Rinder J, Rudehill A, Jansson O, Wiklund NP, et al. Calcium-independent and steroid-resistant nitric oxide synthase activity in human paranasal sinus mucosa. Eur Respir J 1996;9:1344-7. DOI:

Grisham MB, Jourd'Heuil D, Wink DA. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am J Physiol 1999;276:G315-21. DOI:

Huang H, Lavoie-Lamoureux A, Moran K, Lavoie JP. IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and inducible nitric oxide synthase mRNA by equine pulmonary artery endothelial cells. Am J Physiol-Lung C 2007;292:L1147-L54. DOI:

Chibana K, Trudeau JB, Mustovitch AT, Hu H, Zhao J, Balzar S, et al. IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells. Clin Exp Allergy 2008;38:936-46. DOI:

Liaudet L, Soriano FG, Szabo C: Biology of nitric oxide signaling. Crit Care Med 2000;28:N37-N52. DOI:

Bian K, Murad F. What is next in nitric oxide research? From cardiovascular system to cancer biology. Nitric Oxide 2014;43:3-7. DOI:

Maarsingh H, Zaagsma J, Meurs H. Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives. Br J Pharmacol 2009;158:652-64. DOI:

Maniscalco M, Bianco A, Mazzarella G, Motta A. Recent advances on nitric oxide in the upper airways. Curr Med Chem 2016;23:2736-45. DOI:

Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991;181:852-7. DOI:

Paiola G, Tenero L, Piacentini G. The measurement of exhaled nitric oxide in routine practice. Eur Ann Allergy Clin Immunol 2009;41:131-5.

American Thoracic Society; European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171:912-30. DOI:

Linn WS, Berhane KT, Rappaport EB, Bastain TM, Avol EL, Gilliland FD. Relationships of online exhaled, offline exhaled and ambient nitric oxide in an epidemiologic survey of schoolchildren. J Expo Sci Environ Epidemiol 2009;19:674-81. DOI:

Hsu JY, Huang WC, Huang PL, Cheng YW, Chou MC. Usefulness of offline fractional exhaled nitric oxide measurements in the elderly asthmatic patients. Allergy Asthma Proc 2013;34:434-8. DOI:

Maniscalco M, Lundberg JO. Hand-held nitric oxide sensor NIOX MINO(R) for the monitoring of respiratory disorders. Expert Rev Respir Med 2010;4:715-21. DOI:

Maniscalco M, Vitale C, Vatrella A, Molino A, Bianco A, Mazzarella G. Fractional exhaled nitric oxide-measuring devices: technology update. Med Devices (Auckl) 2016;9:151-60. DOI:

Harnan SE, Tappenden P, Essat M, Gomersall T, Minton J, Wong R, et al. Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath. Health Technol Assess 2015;19:1-330. DOI:

Molino A, Fuschillo S, Mosella M, Accardo M, Guida P, Motta A, et al. Comparison of three different exhaled nitric oxide analyzers in chronic respiratory disorders. J Breath Res 2019;13:021002. DOI:

Wang C, Sahay P. Breath analysis using laser spectroscopic techniques: breath biomarkers, spectral fingerprints, and detection limits. Sensors (Basel) 2009;9:8230-62. DOI:

Hunter GW, Xu JC, Biaggi-Labiosa AM, Laskowski D, Dutta PK, Mondal SP, et al. Smart sensor systems for human health breath monitoring applications. J Breath Res 2011;5:037111. DOI:

McCurdy MR, Bakhirkin Y, Wysocki G, Tittel FK. Performance of an exhaled nitric oxide and carbon dioxide sensor using quantum cascade laser-based integrated cavity output spectroscopy. J Biomed Opt 2007;12:034034. DOI:

Mandon J, Högman M, Merkus PJFM, van Amsterdam J, Harren FJM, Cristescu SM. Exhaled nitric oxide monitoring by quantum cascade laser: comparison with chemiluminescent and electrochemical sensors. J Biomed Opt 2012;17:017003. DOI:

Lewicki R, Doty JH, Curl RF, Tittel FK, Wysocki G. Ultrasensitive detection of nitric oxide at 5.33 microm by using external cavity quantum cascade laser-based Faraday rotation spectroscopy. P Natl Acad Sci USA 2009;106:12587-92. DOI:

Shorter JH, Nelson DD, McManus JB, Zahniser MS, Sama SR, Milton DK. Clinical study of multiple breath biomarkers of asthma and COPD (NO, CO(2), CO and N(2)O) by infrared laser spectroscopy. J Breath Res 2011;5:037108. DOI:

Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184:602-15. DOI:

Horváth I, Barnes PJ, Loukides S, Sterk PJ, Högman M, Olin AC, et al. A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Eur Respir J 2017;49:1600965. DOI:

Grob NM, Dweik RA. Exhaled nitric oxide in asthma. From diagnosis, to monitoring, to screening: are we there yet? Chest 2008;133:837-9.

Ahovuo-Saloranta A, Csonka P, Lehtimäki L. Basic characteristics and clinical value of FeNO in smoking asthmatics - a systematic review. J Breath Res 2019;13:034003. DOI:

Haccuria A, Michils A, Michiels S, Van Muylem A. Exhaled nitric oxide: a biomarker integrating both lung function and airway inflammation changes. J Allergy Clin Immunol 2014;134:554-9. DOI:

Malinovschi A1, Janson C, Holmkvist T, Norbäck D, Meriläinen P, Högman M. Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters. Eur Respir J 2006;28:339-45. DOI:

Bobrowska-Korzeniowska M, Stelmach I, Brzozowska A, Jerzyńska J, Mitał M, Stelmach W. The effect of passive smoking on exhaled nitric oxide in asthmatic children. Nitric Oxide 2019;86:48-53. DOI:

Hoyt JC, Robbins RA, Habib M, Springall DR, Buttery LD, Polak JM, et al. Cigarette smoke decreases inducible nitric oxide synthase in lung epithelial cells. Exp Lung Res. 2003;29(1):17-28. DOI:

Kovesi T, Kulka R, Dales R. Exhaled nitric oxide concentration is affected by age, height, and race in healthy 9- to 12-year-old children. Chest 2008;133:169-75. DOI:

Olin A-C, Bake B, Torén K. Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers. Chest 2007;131:1852-6. DOI:

Travers J, Marsh S, Aldington S, Williams M, Shirtcliffe P, Pritchard A, et al. Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med 2007;176:238-42. DOI:

Taylor DR, Mandhane P, Greene JM, Hancox RJ, Filsell S, McLachlan CR, et al. Factors affecting exhaled nitric oxide measurements: the effect of sex. Respir Res 2007;8:82. DOI:

Jacinto T, Malinovschi A, Janson C, Fonseca J, Alving K. Evolution of exhaled nitric oxide levels throughout development and aging of healthy humans. J Breath Res 2015;9:036005. DOI:

Blake TL, Chang AB, Chatfield MD, Petsky HL, Rodwell LT, Brown MG, et al. Does ethnicity influence fractional exhaled nitric oxide in healthy individuals? A systematic review. Chest 2019;156:239-46. DOI:

Wang D, Wang Y, Liang H, David JE, Bray CL. Race and ethnicity have significant influence on fractional exhaled nitric oxide. Ann Allergy Asthma Immunol 2018;120:272-7. DOI:

Borrill Z, Clough D, Truman N, Morris J, Langley S, Singh D. A comparison of exhaled nitric oxide measurements performed using three different analysers. Respir Med 2006;100:1392-6. DOI:

Cattoni I, Guarnieri G, Tosetto A, Mason P, Scarpa MC, Saetta M, et al. Mechanisms of decrease in fractional exhaled nitric oxide during acute bronchoconstriction. Chest 2013;143:1269-76. DOI:

Kharitonov SA, Gonio F, Kelly C, Meah S, Barnes PJ. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J 2003;21:433-8. DOI:

Olivieri M, Talamini G, Corradi M, Perbellini L, Mutti A, Tantucci C, et al. Reference values for exhaled nitric oxide (reveno) study. Respir Res 2006;7:94. DOI:

Buchvald F, Baraldi E, Carraro S, Gaston B, De Jongste J, Pijnenburg MWH, et al. Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol 2005;115:1130-6. DOI:

Cho HJ, Jung YH, Yang SI, Lee E, Kim HY, Seo JH, et al. Reference values and determinants of fractional concentration of exhaled nitric oxide in healthy children. Allergy Asthma Immunol Res 2014;6:169-74. DOI:

Malmberg LP, Petäys T, Haahtela T, Laatikainen T, Jousilahti P, Vartiainen E, et al. Exhaled nitric oxide in healthy nonatopic school-age children: determinants and height-adjusted reference values. Pediatr Pulmonol 2006;41:635-42. DOI:

Olin A-C, Rosengren A, Thelle DS, Lissner L, Bake B, Torén K. Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest 2006;130:1319-25. DOI:

de Abreu FC, da Silva Júnior JLR, Rabahi MF. The fraction exhaled nitric oxide as a biomarker of asthma control. Biomark Insights 2019;14:1177271919826550. DOI:

Alvarez-Puebla MJ, Olaguibel Rivera JM, Almudevar E, Echegoyen AA, de Esteban Chocarro B, Cambra K. Cutoff point for exhaled nitric oxide corresponding to 3% sputum eosinophils. J Investig Allergol Clin Immunol 2015;25:107-11.

Ekroos H, Karjalainen J, Sarna S, Laitinen LA, Sovijarvi AR. Short-term variability of exhaled nitric oxide in young male patients with mild asthma and in healthy subjects. Respir Med 2002;96:895-900. DOI:

Pijnenburg MW, Floor SE, Hop WC, De Jongste JC. Daily ambulatory exhaled nitric oxide measurements in asthma. Pediatr Allergy Immunol 2006;17:189-93. DOI:

Massaro AF, Gaston B, Kita D, Fanta C, Stamler JS, Drazen JM. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995;152:800-3. DOI:

Beck-Ripp J, Griese M, Arenz S, Koring C, Pasqualoni B, Bufler P. Changes of exhaled nitric oxide during steroid treatment of childhood asthma. Eur Respir J 2002;19:1015-9. DOI:

Jones SL, Kittelson J, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001;164:738-43. DOI:

Michils A, Baldassarre S, Van Muylem A. Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients. Eur Respir J 2008;31:539-46. DOI:

Rolla G, Malinovschi A, Badiu I, Heffler E, Petrarulo M, Bucca C, et al. The increase in exhaled NO following allergen challenge is not associated with airway acidification. Eur J Clin Invest 2011;41:411-6. DOI:

Ferrazzoni S, Scarpa MC, Guarnieri G, Corradi M, Mutti A, Maestrelli P. Exhaled nitric oxide and breath condensate ph in asthmatic reactions induced by isocyanates. Chest 2009;136:155-62. DOI:

George SC, Hogman M, Permutt S, Silkoff PE. Modeling pulmonary nitric oxide exchange. J Appl Physiol (1985) 2004;96:831-9. DOI:

Hogman M, Malinovschi A, Norback D, Janson C. Added value with extended NO analysis in atopy and asthma. Clin Physiol Funct Imaging 2011;31:294-9. DOI:

Högman M. Extended NO analysis in health and disease. J Breath Res 2012;6:047103. DOI:

van Veen IH, Sterk PJ, Schot R, Gauw SA, Rabe KF, Bel EH. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J 2006;27:951-6. DOI:

Maniscalco M, Faraone S, Sofia M, Molino A, Vatrella A, Zedda A. Extended analysis of exhaled and nasal nitric oxide for the evaluation of chronic cough. Respir Med 2015;109:970-4. DOI:

National Institute for Health Care Excellence. NICE guideline NG80. Available at:

Rupani H, Chauhan AJ. Measurement of FeNO in asthma: what the hospital doctor needs to know. Br J Hosp Med (Lond) 2019;80:99-104. DOI:

Feng-Jia C, Xin-Yan H, Geng-Peng L, Yang-Li L, Can-Mao X. Validity of fractional exhaled nitric oxide and small airway function indices in diagnosis of cough-variant asthma. J Asthma 2018;55:750-5. DOI:

Song WJ, Kim HJ, Shim JS, Won HK, Kang SY, Sohn KH, et al. Diagnostic accuracy of fractional exhaled nitric oxide measurement in predicting cough-variant asthma and eosinophilic bronchitis in adults with chronic cough: A systematic review and meta-analysis. J Allergy Clin Immunol 2017;140:701-9.

Saito M, Kikuchi Y, Lefor AK. School-aged asthma children with high fractional exhaled nitric oxide levels and lung dysfunction are at high risk of prolonged lung dysfunction. Asia Pac Allergy 2019;9:e8. DOI:

Zhang L, Liu S, Li M, Xu X. Diagnostic value of fractional exhaled nitric oxide in cough-variant asthma: an updated meta-analysis. J Asthma 2019. doi: 10.1080/02770903.2019.1568452. DOI:

Pijnenburg MW. The role of FeNO in predicting asthma. Front Pediatr 2019;7:41. DOI:

British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. SIGN 153. 2016. Available at:

Karrasch S, Linde K, Rücker G, Sommer H, Karsch-Völk M, Kleijnen J, et al. Accuracy of FENO for diagnosing asthma: a systematic review. Thorax 2017;72:109-16. DOI:

Jackson DJ, Virnig CM, Gangnon RE, Evans MD, Roberg KA, Anderson EL, et al. Fractional exhaled nitric oxide measurements are most closely associated with allergic sensitization in school-age children. J Allergy Clin Immunol 2009;124:949-53. DOI:

Janson C, Kalm-Stephens P, Foucard T, Norbäck D, Alving K, Nordvall SL. Exhaled nitric oxide levels in school children in relation to IgE sensitisation and window pane condensation. Respir Med 2005;99:1015-21. DOI:

Malinovschi A, Janson C, Holmkvist T, Norbäck D, Meriläinen P, Högman M. IgE sensitization in relation to flow-independent nitric oxide exchange parameters. Respir Res 2006;7:92. DOI:

Kalm-Stephens P, Nordvall L, Janson C, Neuman Å, Malinovschi A, Alving K. Elevated exhaled nitric oxide in adolescents relates to incident allergic symptoms: a prospective cohort study.J Investig Allergol Clin Immunol 2019;29:231-8. DOI:

Linhares D, Jacinto T, Pereira AM, Fonseca JA. Effects of atopy and rhinitis on exhaled nitric oxide values - a systematic review. Clin Transl Allergy 2011;1:8. DOI:

Kalpaklioglu AF, Kalkan IK. Comparison of orally exhaled nitric oxide in allergic versus nonallergic rhinitis. Am J Rhinol Allergy 2012;26:e50-4. DOI:

Lopuhaä CE, Koopmans JG, Jansen HM, van der Zee JS. Similar levels of nitric oxide in exhaled air in non-asthmatic rhinitis and asthma after bronchial allergen challenge. Allergy 2003;58:300-5. DOI:

Bergmann-Hug K, Wirth R, Henseler M, Helbling A, Pichler WJ, Schnyder B. Effect of natural seasonal pollen exposure and repeated nasal allergen provocations on elevation of exhaled nitric oxide. Allergy 2009;64:1629-34. DOI:

Heffler E, Guida G, Marsico P, Bergia R, Bommarito L, Ferrero N, et al. Exhaled nitric oxide as a diagnostic test for asthma in rhinitic patients with asthmatic symptoms. Respir Med 2006;100:1981-7. DOI:

Rolla G, Guida G, Heffler E, Badiu I, Bommarito L, De Stefani A, et al. Diagnostic classification of persistent rhinitis and its relationship to exhaled nitric oxide and asthma: a clinical study of a consecutive series of patients. Chest 2007;131:1345-52. DOI:

Ciprandi G, Gallo F, Ricciardolo FL, Cirillo I. Fractional exhaled nitric oxide: A potential biomarker in allergic rhinitis? Int Arch Allergy Immunol 2017;172:99-105. DOI:

Kambaraa R, Minami T, Akazawa H, Tsuji F, Sasaki T, Inohara H, Horii A. Lower airway inflammation in eosinophilic chronic rhinosinusitis as determined by exhaled nitric oxide. Int Arch Allergy Immunol 2017;173:225-32. DOI:

Guida G, Rolla G, Badiu I, Marsico P, Pizzimenti S, Bommarito L, De Stefani A, Usai A, Bugiani M, Malinovschi A, Bucca C, Heffler E. Determinants of exhaled nitric oxide in chronic rhinosinusitis. Chest 2010;137:658-64. DOI:

Pavlidis S, Takahashi K, Ng Kee Kwong F, Xie J, Hoda U, et al. "T2-high" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin. Eur Respir J 2019;53. doi: 10.1183/13993003.00938-2018. DOI:

Mansur AH, Srivastava S, Sahal A. Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function. Respir Med 2018;143:31-8. DOI:

Lehtimäki L, Csonka P, Mäkinen E, Isojärvi J, Hovi SL, Ahovuo-Saloranta A. Predictive value of exhaled nitric oxide in the management of asthma: a systematic review. Eur Respir J 2016;48:706-14. DOI:

Bates CA, Silkoff PE. Exhaled nitric oxide in asthma: From bench to bedside. J Allergy Clin Immunol 2003;111:256-62. DOI:

Oka A, Hirano T, Yamaji Y, Ito K, Oishi K, Edakuni N, Kawano R, Matsunaga K. Determinants of incomplete asthma control in patients with allergic rhinitis and asthma. J Allergy Clin Immunol Pract 2017;5:160-4. DOI:

Ricciardolo FL, Sorbello V, Bellezza Fontana R, Schiavetti I, Ciprandi G. Exhaled nitric oxide in relation to asthma control: A real-life survey. Allergol Immunopathol (Madr) 2016;44:197-205. DOI:

Shirai T, Furuhashi K, Suda T, Chida K. Relationship of the asthma control test with pulmonary function and exhaled nitric oxide. Ann Allergy Asthma Immunol 2008;101:608-13. DOI:

Zeng J, Chen Z, Hu Y, Hu Q, Zhong S, Liao W. Asthma control in preschool children with small airway function as measured by IOS and fractional exhaled nitric oxide. Respir Med 2018;145:8-13. DOI:

Piacentini GL, Peroni DG, Bodini A, Bonafiglia E, Rigotti E, Baraldi E, et al. Childhood asthma control test and airway inflammation evaluation in asthmatic children. Allergy 2009;64:1753-7. DOI:

Lee WY, Suh DI, Song DJ, Baek HS, Shin M, Yoo Y, et al. Asthma control test reflects not only lung function but also airway inflammation in children with stable asthma. J Asthma. 2019;10:1-6. DOI:

Heffler E, Pizzimenti S, Badiu I, Guida G, Ricciardolo FL, Bucca C, et al. Nasal nitric oxide is a marker of poor asthma control. J Breath Res 2013;7:026009. DOI:

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Togawa R, et al. The clinical role of fractional exhaled nitric oxide in asthma control. Ann Allergy Asthma Immunol 2017;119:541-7. DOI:

Meena RK, Raj D, Lodha R, Kabra SK. Fractional exhaled nitric oxide for identification of uncontrolled asthma in children. Indian Pediatr 2016;53:307-10. DOI:

Mahut B, Trinquart L, Le Bourgeois M, Becquemin MH, Beydon N, Aubourg F, et al. Multicentre trial evaluating alveolar NO fraction as a marker of asthma control and severity. Allergy. 2010;65:636-44. DOI:

Bernstein JA, Davis B, Alvarez-Puebla MJ, Nguyen D, Levin L, Olaguibel JM. Is exhaled nitric oxide a useful adjunctive test for assessing asthma? J Asthma 2009;46:955-60. DOI:

Lopes C, Fonseca J, Delgado L, Moreira A, Barros R, Moreira P, et al. Assessing asthma control: questionnaires and exhaled nitric oxide provide complementary information. Eur Respir J 2008;32:1419-20. DOI:

Fielding S, Pijnenburg M, de Jongste JC, Pike KC, Roberts G, Petsky H, et al. Change in FEV1 and feno measurements as predictors of future asthma outcomes in children. Chest 2019;155:331-41. DOI:

Wang Z, Pianosi P, Keogh K, Zaiem F, Alsawas M, Alahdab F, et al. The clinical utility of fractional exhaled nitric oxide (FeNO) in asthma management. Report No: 17(18)-EHC030-EF. Rockville, MD: Agency for Healthcare Research and Quality (US); 2017;. DOI:

Visitsunthorn N, Prottasan P, Jirapongsananuruk O, Maneechotesuwan K. Is fractional exhaled nitric oxide (FeNO) associated with asthma control in children? Asian Pac J Allergy Immunol 2014;32:218-25. DOI:

Martins C, Silva D, Severo M, Rufo J, Paciência I, Madureira J, et al. Spirometry-adjusted fraction of exhaled nitric oxide increases accuracy for assessment of asthma control in children. Pediatr Allergy Immunol 2017;28:754-62. DOI:

Michils A, Haccuria A, Michiels S, Van Muylem A. Airway calibre variation is a major determinant of exhaled nitric oxide's ability to capture asthma control. Eur Respir J 2017;50: 1700392. DOI:

Malinovschi A, Van Muylem A, Michiels S, Michils A. FeNO as a predictor of asthma control improvement after starting inhaled steroid treatment. Nitric Oxide 2014;40:110-6. DOI:

Chang DV, Teper A, Balinotti J, Castro Simonelli C, Garcia-Bournissen F, Kofman C. Exhaled nitric oxide predicts loss of asthma control in children after inhaled corticosteroids withdrawal. Pediatr Pulmonol 2019;54:537-43.

Kim JK, Jung JY, Kim H, Eom SY, Hahn YS. Combined use of fractional exhaled nitric oxide and bronchodilator response in predicting future loss of asthma control among children with atopic asthma. Respirology 2017;22:466-72. DOI:

Matsunaga K, Hirano T, Oka A, Ito K, Edakuni N. Persistently high exhaled nitric oxide and loss of lung function in controlled asthma. Allergol Int 2016;65:266-71. DOI:

Yang S, Park J, Lee YK, Kim H, Hahn YS. Association of longitudinal fractional exhaled nitric oxide measurements with asthma control in atopic children. Respir Med 2015;109:572-9. DOI:

Little SA, Chalmers GW, MacLeod KJ, McSharry C, Thomson NC. Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax 2000;55:232-4. DOI:

McNicholl DM, Stevenson M, McGarvey LP, Heaney LG. The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma. Am J Respir Crit Care Med 2012;186:1102-8. DOI:

Petsky HL, Cates CJ, Kew KM, Chang AB. Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis. Thorax 2018;73:1110-9. DOI:

SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002;109:410-8. DOI:

Price DB, Buhl R, Chan A, Freeman D, Gardener E, Godley C, et al. Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial. Lancet Respir Med 2018;6:29-39. DOI:

Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax 2010;65:384-90. DOI:

Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005;115:233-42. DOI:

Cowan DC, Taylor DR, Peterson LE, Cowan JO, Palmay R, Williamson A, et al. Biomarker-based asthma phenotypes of corticosteroid response. J Allergy Clin Immunol 2015;135:877-83. DOI:

Smith AD, Cowan JO, Brassett KP, Filsell S, McLachlan C, Monti-Sheehan G, et al. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med 2005;172:453-9. DOI:

Hoshino M, Akitsu K, Ohtawa J. Comparison between montelukast and tiotropium as add-on therapy to inhaled corticosteroids plus a long-acting β2-agonist in for patients with asthma. J Asthma 2018;13:1-9.

Fritscher LG1, Rodrigues MT, Zamel N, Chapman KR. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Respir Med 2009;103:296-300. DOI:

Davis BE, Illamperuma C, Gauvreau GM, Watson RM, O'Byrne PM, Deschesnes F, et al. Single-dose desloratadine and montelukast and allergen-induced late airway responses. Eur Respir J 2009;33:1302-8. DOI:

Kononowa N, Michel S, Miedinger D, Pichler CE, Chhajed PN, Helbling A, et al. Effects of add-on montelukast on airway hyperresponsiveness in patients with well-controlled asthma - a pilot study. J Drug Assess 2013;2:49-57. DOI:

Montuschi P, Mondino C, Koch P, Ciabattoni G, Barnes PJ, Baviera G. Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma. Chest 2007;132:1876-81. DOI:

Moeller A, Lehmann A, Knauer N, Albisetti M, Rochat M, Johannes W. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children. Pediatr Pulmonol 2008;43:179-86. DOI:

Tenero L, Piazza M, Sandri M, Azzali A, Chinellato I, Peroni D, et al. Effect of montelukast on markers of airway remodeling in children with asthma. Allergy Asthma Proc 2016;37:77-83. DOI:

Lehtimäki L, Petäys T, Haahtela T. Montelukast is not effective in controlling allergic symptoms outside the airways: a randomised double-blind placebo-controlled crossover study. Int Arch Allergy Immunol 2009;149:150-3. DOI:

Pelkonen AS, Malmström K, Sarna S, Kajosaari M, Klemola T, Malmberg LP, et al. The effect of montelukast on respiratory symptoms and lung function in wheezy infants. Eur Respir J 2013;41:664-70. DOI:

Zeiger RS, Schatz M, Zhang F, Crawford WW, Kaplan MS, Roth RM, et al. Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids. J Allergy Clin Immunol 2011;128:412-4. DOI:

Petsky HL, Kew KM, Turner C, Chang AB. Exhaled nitric oxide levels to guide treatment for adults with asthma. Cochrane Database Syst Rev 2016;9:CD011440. DOI:

Petsky HL, Kew KM, Chang AB. Exhaled nitric oxide levels to guide treatment for children with asthma. Cochrane Database Syst Rev 2016;11:CD011439. DOI:

Petsky HL, Li A, Chang AB. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 2017;8:CD005603. DOI:

Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J, et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 2011;66:910-7. DOI:

Braido F, Baiardini I, Blasi F, Pawankar R, Canonica GW. Adherence to asthma treatments: 'we know, we intend, we advocate'. Curr Opin Allergy Clin Immunol 2015;15:49-55. DOI:

Delgado-Corcoran C, Kissoon N, Murphy SP, Duckworth LJ. Exhaled nitric oxide reflects asthma severity and asthma control. Pediatr Crit Care Med 2004;5:48-52. DOI:

Cano-Garcinuño A, Carvajal-Urueña I, Díaz-Vázquez CA, Domínguez-Aurrecoechea B, García-Merino A, de Rodas PM, et al. Clinical correlates and determinants of airway inflammation in pediatric asthma. J Investig Allergol Clin Immunol 2010;20:303-10.

Klok T, Brand PLP. Can exhaled nitric oxide fraction predict adherence to inhaled corticosteroids in atopic and nonatopic children with asthma? J Allergy Clin Immunol Pract 2017;5:521-2. DOI:

Tsai YG, Sun HL, Chien JW, Chen CY, Lin CH, Lin CY. High exhaled nitric oxide levels correlate with nonadherence in acute asthmatic children. Ann Allergy Asthma Immunol 2017;118:521-3. DOI:

Hunt E, Flynn D, MacHale E, Costello RW, Murphy DM. Reduction in exhaled nitric oxide tracks improved patient inhaler compliance in difficult asthma-a case study. Asthma 2018;55:1373-5. DOI:

Heaney LG, Busby J, Bradding P, Chaudhuri R, Mansur AH, Niven R, et al. remotely monitored therapy and nitric oxide suppression identifies nonadherence in severe asthma. Am J Respir Crit Care Med 2019;199:454-64. DOI:

Price DB, Bosnic-Anticevich S, Pavord ID, Roche N, Halpin DMG, Bjermer L, et al. Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations. Clin Transl Allergy 2019;9:41. DOI:

Katsara M, Donnelly D, Iqbal S, Elliott T, Everard ML. Relationship between exhaled nitric oxide levels and compliance with inhaled corticosteroids in asthmatic children. Respir Med 2006;100:1512-7. DOI:

Busby J, Holweg CTJ, Chai A, Bradding P, Cai F, Chaudhuri R, et al. Change in type-2 biomarkers and related cytokines with prednisolone in uncontrolled severe oral corticosteroid dependent asthmatics : an interventional open-label study. Thorax 2019:1-4. DOI:

Oishi K, Hirano T, Suetake R, Ohata S, Yamaji Y, Ito K, et al. A trial of oral corticosteroids for persistent systemic and airway inflammation in severe asthma. Immun Inflamm Dis 2017:5:261-4. DOI:

Hanania NA, Wenzel S, Rosén K, Hsieh HJ, Mosesova S, Choy DF, et al. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med 2013;187:804-11. DOI:

Bhutani M, Yang WH, Hébert J, de Takacsy F, Stril JL. The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational study. PLoS One 2017;12:e0183869. DOI:

Kurokawa M, Koya T, Takeuchi H, Hayashi M, Sakagami T, Ishioka K, et al. Association of upper and lower airway eosinophilic inflammation with response to omalizumab in patients with severe asthma. J Asthma 2020;57:71-8. DOI:

Pasha MA, Jourd'heuil D, Jourd'heuil F, Mahon L, Romero F, Feustel PJ, et al. The effect of omalizumab on small airway inflammation as measured by exhaled nitric oxide in moderate-to-severe asthmatic patients. Allergy Asthma Proc 2014;35:241-9. DOI:

Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, Ortega H, Chanez P. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 2012;380:651-9. DOI:

Farah CS, Badal T, Reed N, Rogers PG, King GG, Thamrin C, Peters MJ, Seccombe LM. Mepolizumab improves small airway function in severe eosinophilic asthma. Respir Med 2019;148:49-53. DOI:

Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, et al. dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med 2018;378:2486-96. DOI:

Wenzel S, Pavord ID, Rabe KF, Papi A, Fitzgerald JM, Jagerschmidt A, et al. Dupilumab shows rapid and sustained suppression of inflammatory biomarkers in asthma patients in LIBERTY ASTHMA QUEST. Eur Respir J. 2018;52:PA5005. DOI:

Luo J, Liu D, Liu CT. The efficacy and safety of anti-interleukin 13, a monoclonal antibody, in adult patients with asthma: A systematic review and meta-analysis. Medicine (Baltimore) 2016;95:e2556. DOI:

Panettieri RA Jr, Sjöbring U, Péterffy A, Wessman P, Bowen K, Piper E, et al. Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials. Lancet Respir Med 2018;6:511-25. DOI:

Russell RJ, Chachi L, FitzGerald JM, Backer V, Olivenstein R, Titlestad IL, et al. Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial. Lancet Respir Med 2018;6:499-510. DOI:

Corren J, Parnes JR, Wang L, Mo M, Roseti SL, Griffiths JM, et al. Tezepelumab in adults with uncontrolled asthma. N Engl J Med 2017;377:936-46. DOI:

Soma T, Iemura H, Naito E, Miyauchi S, Uchida Y, Nakagome K, et al. Implication of fraction of exhaled nitric oxide and blood eosinophil count in severe asthma. Allergol Int 2018;67S:S3-11. DOI:

Nelson BV, Sears S, Woods J, Ling CY, Hunt J, Clapper LM, Gaston B. Expired nitric oxide as a marker for childhood asthma. J Pediatr 1997;130:423-7. DOI:

Baraldi E, Azzolin NM, Zanconato S, Dario C, Zacchello F. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J Pediatr 1997;131:381-5. DOI:

Baraldi E, de Jongste JC, European Respiratory Society/American Thoracic Society (ERS/ATS) Task Force. Measurement of exhaled nitric oxide in children, 2001. Eur Respir J 2002;20:223-37. DOI:

Ferraro V, Carraro S, Bozzetto S, Zanconato S, Baraldi E. Exhaled biomarkers in childhood asthma: old and new approaches. Asthma Res Pract 2018;4:9. DOI:

Mahr TA, Malka J, Spahn JD. Inflammometry in pediatric asthma: a review of fractional exhaled nitric oxide in clinical practice. Allergy Asthma Proc 2013;34:210-9. DOI:

Cibella F, Cuttitta G, La Grutta S, Passalacqua G, Viegi G. Factors that influence exhaled nitric oxide in Italian schoolchildren. Ann Allergy Asthma Immunol 2008;101:407-12. DOI:

Dodig S, Richter D, Zrinski-Topić R. Inflammatory markers in childhood asthma. Clin Chem Lab Med 2011;49:587-99. DOI:

Moeller A, Carlsen KH, Sly PD, Baraldi E, Piacentini G, Pavord I, et al. Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation. Eur Respir Rev 2015;24:204-15. DOI:

Oh MA, Shim JY, Jung YH, Seo JH, Young Kim H, Kwon JW, et al. Fraction of exhaled nitric oxide and wheezing phenotypes in preschool children. Pediatr Pulmonol 2013;48:563-70. DOI:

Caudri D, Wijga AH, Hoekstra MO, Kerkhof M, Koppelman GH, Brunekreef B, et al. Prediction of asthma in symptomatic preschool children using exhaled nitric oxide, rint and specific IgE. Thorax 2010;65:801-7. DOI:

Hervás D, Milán JM, Garde J. Differences in exhaled nitric oxide in atopic children. Allergol Immunopathol (Madr) 2008;36:331-5. DOI:

Scott M, Raza A, Karmaus W, Mitchell F, Grundy J, Kurukulaaratchy RJ, et al. Influence of atopy and asthma on exhaled nitric oxide in an unselected birth cohort study. Thorax 2010;65:258-62. DOI:

Chinellato I, Piazza M, Peroni D, Sandri M, Chiorazzo F, Boner AL, et al. Bronchial and alveolar nitric oxide in exercise-induced bronchoconstriction in asthmatic children. Clin Exp Allergy 2012;42:1190-6. DOI:

Ferrer M, Jarque A, Tosca R, Michavila A. Is it necessary to treat all asthmatic children with raised levels of exhaled nitric oxide?: treating the patient or the data. Allergol Immunopathol (Madr) 2011;39:280-3. DOI:

Silvestri M, Sabatini F, Spallarossa D, Fregonese L, Battistini E, Biraghi MG, et al. Exhaled nitric oxide levels in non-allergic and allergic mono- or polysensitised children with asthma. Thorax 2001;56:857-62. DOI:

Baraldi E, Azzolin NM, Cracco A, Zacchello F. Reference values of exhaled nitric oxide for healthy children 6-15 years old. Pediatr Pulmonol 1999;27:54-8. DOI:<54::AID-PPUL10>3.0.CO;2-V

Ferrante G, Malizia V, Antona R, Corsello G, Grutta S. The value of FeNO measurement in childhood asthma: uncertainties and perspectives. Multidiscip Respir Med 2013;8:50. DOI:

La Grutta S, Ferrante G, Malizia V, Cibella F, Viegi G. Environmental effects on fractional exhaled nitric oxide in allergic children. J Allergy (Cairo) 2012;2012:916926. DOI:

Ricciardolo FL, Silvestri M, Pistorio A, Strozzi MM, Tosca MA, Bellodi SC, et al. Determinants of exhaled nitric oxide levels (FeNO) in childhood atopic asthma: evidence for neonatal respiratory distress as a factor associated with low FeNO levels. J Asthma 2010;47:810-6. DOI:

Filippone M, Bonetto G, Corradi M, Frigo AC, Baraldi E. Evidence of unexpected oxidative stress in airways of adolescents born very pre-term. Eur Respir J 2012;40:1253-9. DOI:

Moeller A, Diefenbacher C, Lehmann A, Rochat M, Brooks-Wildhaber J, Hall GL, et al. Exhaled nitric oxide distinguishes between subgroups of preschool children with respiratory symptoms. J Allergy Clin Immunol 2008;121:705-9. DOI:

Singer F, Luchsinger I, Inci D, Knauer N, Latzin P, Wildhaber JH, et al. Exhaled nitric oxide in symptomatic children at preschool age predicts later asthma. Allergy 2013;68:531-8. DOI:

Chang D, Yao W, Tiller CJ, Kisling J, Slaven JE, Yu Z, et al. Exhaled nitric oxide during infancy as a risk factor for asthma and airway hyperreactivity. Eur Respir J 2015;45:98-106. DOI:

Jartti T, Wendelin-Saarenhovi M, Heinonen I, Hartiala J, Vanto T. Childhood asthma management guided by repeated FeNO measurements: a meta-analysis. Paediatr Respir Rev 2012;13:178-83. DOI:

Petsky HL, Cates CJ, Li A, Kynaston JA, Turner C, Chang AB. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 2009;:CD006340. DOI:

Wadsworth S, Sin D, Dorscheid D. Clinical update on the use of biomarkers of airway inflammation in the management of asthma. J Asthma Allergy 2011;4:77-86. DOI:

Green RJ, Klein M, Becker P, Halkas A, Lewis H, Kitchin O, et al. Disagreement among common measures of asthma control in children. Chest 2013;143:117-22. DOI:

Bodini A, Peroni D, Loiacono A, Costella S, Pigozzi R, Baraldi E, et al. Exhaled nitric oxide daily evaluation is effective in monitoring exposure to relevant allergens in asthmatic children. Chest 2007;132:1520-5. DOI:

Cabral AL, Vollmer WM, Barbirotto RM, Martins MA. Exhaled nitric oxide as a predictor of exacerbation in children with moderate-to-severe asthma: a prospective, 5-month study. Ann Allergy Asthma Immunol 2009;103:206-11. DOI:

Stern G, de Jongste J, van der Valk R, Baraldi E, Carraro S, Thamrin C, Frey U. Fluctuation phenotyping based on daily fraction of exhaled nitric oxide values in asthmatic children. J Allergy Clin Immunol 2011;128:293-300. DOI:

Gagliardo R, La Grutta S, Chanez P, Profita M, Paternò A, Cibella F, et al. Non-invasive markers of airway inflammation and remodeling in childhood asthma. Pediatr Allergy Immunol 2009;20:780-90. DOI:

van der Valk RJ, Baraldi E, Stern G, Frey U, de Jongste JC. Daily exhaled nitric oxide measurements and asthma exacerbations in children. Allergy 2012;67:265-71. DOI:

Chang DV, Teper A, Balinotti J, Castro Simonelli C, Garcia-Bournissen F, Kofman C. Exhaled nitric oxide predicts loss of asthma control in children after inhaled corticosteroids withdrawal. Pediatr Pulmonol 2019;54:537-43. DOI:

Waibel V, Ulmer H, Horak E. Assessing asthma control: symptom scores, GINA levels of asthma control, lung function, and exhaled nitric oxide. Pediatr Pulmonol 2012;47:113-118. DOI:

Lu Z, Huang W, Wang L, Xu N, Ding Q, Cao C. Exhaled nitric oxide in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 2018;13:2695-705. DOI:

Zietkowski Z, Kucharewicz I, Bodzenta-Lukaszyk A. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease. Respir Med 2005;99:816-24. DOI:

Dummer JF, Epton MJ, Cowan JO, Cook JM, Condliffe R, Landhuis CE, et al. Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide. Am J Respir Crit Care Med 2009;180:846-52. DOI:

Lehtimaki L, Kankaanranta H, Saarelainen S, Annila I, Aine T, Nieminen R, et al. Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD. Eur Respir J 2010;35:72-8. DOI:

Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:418-24. DOI:

Global Initiative for Asthma, Global Initiative for Chronic Obstructive Lung Disease. Diagnosis of disease of chronic airflow limitation: Asthma, COPD, and asthma-COPD overlap syndrome (ACOS). Available at:

Takayama Y, Ohnishi H, Ogasawara F, Oyama K, Kubota T, Yokoyama A. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap. Int J Chron Obstruct Pulmon Dis 2018;13:2525-32. DOI:

Hatipoğlu U, Rubinstein I. Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 2003;70:665-71. DOI:

Duarte RLM, Rabahi MF, Oliveira-E-Sá TS, Magalhães-da-Silveira FJ, Mello FCQ, Gozal D. Fractional exhaled nitric oxide measurements and screening of obstructive sleep apnea in a sleep-laboratory setting: A cross-sectional study. Lung 2019;197:131-7. DOI:

Zhang D, Luo J, Qiao Y, Xiao Y, Huang R, Zhong X. Measurement of exhaled nitric oxide concentration in patients with obstructive sleep apnea: A meta-analysis. Medicine (Baltimore) 2017;96):e6429. DOI:

Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE. Chronic cough: eosinophilic bronchitis without asthma. Lancet 1989;1:1346-8. DOI:

Oh MJ, Lee JY, Lee BJ, Choi DC. Exhaled nitric oxide measurement is useful for the exclusion of nonasthmatic eosinophilic bronchitis in patients with chronic cough. Chest 2008;134:990-5. DOI:

Song WJ, Kim HJ, Shim JS, Won HK, Kang SY, Sohn KH, et al. Diagnostic accuracy of fractional exhaled nitric oxide measurement in predicting cough-variant asthma and eosinophilic bronchitis in adults with chronic cough: A systematic review and meta-analysis. J Allergy Clin Immunol 2017;140:701-9. DOI:

Lee JE, Rhee CK, Lim JH, Lee SM, Shim YS, Lee CT, et al. Fraction of exhaled nitric oxide in patients with acute eosinophilic pneumonia. Chest 2012;141:1267-72. DOI:

Oishi K, Hirano T, Suetake R, Ohata S, Yamaji Y, Ito K, et al. Exhaled nitric oxide measurements in patients with acute-onset interstitial lung disease. J Breath Res 2017;11:036001. DOI:

Park JY, Lee T, Lee H, Lee YJ, Park JS, Cho YJ, et al. Significance of fractional exhaled nitric oxide in chronic eosinophilic pneumonia: a retrospective cohort study. BMC Pulm Med 2014;14:81. DOI:

Lundberg JO, Farkas-Szallasi T, Weitzberg E, Rinder J, Lidholm J, Anggåard A, et al. High nitric oxide production in human paranasal sinuses. Nat Med 1995;1:370-3. DOI:

Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993;6:1368-70.

Lundberg JO, Weitzberg E. Nasal nitric oxide in man. Thorax 1999;54:947-52. DOI:

Kawamoto H, Takumida M, Takeno S, Watanabe H, Fukushima N, Yajin K. Localization of nitric oxide synthase in human nasal mucosa with nasal allergy. Acta Otolaryngol Suppl. 1998;539:65-70. DOI:

Mancinelli RL, McKay CP. Effects of nitric oxide and nitrogen dioxide on bacterial growth. Appl Environ Microbiol 1983;46:198-202. DOI:

Gerlach H, Rossaint R, Pappert D, Knorr M, Falke KJ. Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet 1994;343:518-9. DOI:

Lundberg JO. Airborne nitric oxide: inflammatory marker and aerocrine messenger in man. Acta Physiol Scand Suppl 1996;633:1-27. DOI:

Holden WE, Wilkins JP, Harris M, Milczuk HA, Giraud GD. Temperature conditioning of nasal air: effects of vasoactive agents and involvement of nitric oxide. J Appl Physiol 1999;87:1260-5. DOI:

Lundberg JO, Lundberg JM, Settergren G, Alving K, Weitzberg E. Nitric oxide, produced in the upper airways, may act in an 'aerocrine' fashion to enhance pulmonary oxygen uptake in humans. Acta Physiol Scand 1995;155:467-8. DOI:

Knowles MR, Daniels LA, Davis SD, Zariwala MA, Leigh MW. Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease. Am J Respir Crit Care Med 2013;188:913-22. DOI:

Corbelli R, Bringolf-Isler B, Amacher A, Sasse B, Spycher M, Hammer J. Nasal nitric oxide measurements to screen children for primary ciliary dyskinesia. Chest 2004;126:1054-9. DOI:

Leigh MW, Hazucha MJ, Chawla KK, Baker BR, Shapiro AJ, Brown DE, et al. Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia. Ann Am Thorac Soc 2013;10:574-81. DOI:

Collins SA, Behan L, Harris A, Gove K, Lucas JS. The dangers of widespread nitric oxide screening for primary ciliary dyskinesia. Thorax 2016;71:560-1. DOI:

Thomas SR, Kharitonov SA, Scott SF, Hodson ME, Barnes PJ. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype. Chest 2000;117:1085-9. DOI:

Balfour-Lynn IM, Laverty A, Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child 1996;75:319-22. DOI:

Duong-Quy S, Vu-Minh T, Hua-Huy T, Tang-Thi-Thao T, Le-Quang K, Tran-Thanh D, et al. Study of nasal exhaled nitric oxide levels in diagnosis of allergic rhinitis in subjects with and without asthma. J Asthma Allergy 2017;10:75-82. DOI:

Bommarito L, Guida G, Heffler E, Badiu I, Nebiolo F, Usai A, De Stefani A, Rolla G. Nasal nitric oxide concentration in suspected chronic rhinosinusitis. Ann Allergy Asthma Immunol 2008;101:358-62. DOI:

Lee JM, McKnight CL, Aves T, Yip J, Grewal AS, Gupta S. Nasal nitric oxide as a marker of sinus mucosal health in patients with nasal polyposis. Int Forum Allergy Rhinol 2015;5:894-9. DOI:

Phillips PS, Sacks R, Marcells GN, Cohen NA, Harvey RJ. Nasal nitric oxide and sinonasal disease: a systematic review of published evidence. Otolaryngol Head Neck Surg 2011;144:159-69. DOI:

Maniscalco M, Sofia M, Carratu L, Higenbottam T. Effect of nitric oxide inhibition on nasal airway resistance after nasal allergen challenge in allergic rhinitis. Eur J Clin Invest 2001;31:462-6. DOI:

Maniscalco M, Pelaia G, Sofia M. Exhaled nasal nitric oxide during humming: potential clinical tool in sinonasal disease? Biomark Med 2013;7:261-6. DOI:

Ren L, Zhang W, Zhang Y, Zhang L. Nasal nitric oxide is correlated with nasal patency and nasal symptoms. Allergy Asthma Immunol Res 2019;11:367-80. DOI:

Ragab SM, Lund VJ, Saleh HA, Scadding G. Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy. Allergy. 2006;61(6):717-24. DOI:

Liu C, Zheng M, He F, Wang X, Zhang L.Role of exhaled nasal nitric oxide in distinguishing between chronic rhinosinusitis with and without nasal polyps. Am J Rhinol Allergy 2017;31:389-94. DOI:

Yoshida K, Takabayashi T, Imoto Y et al. Reduced nasal nitric oxide levels in patients with eosinophilic chronic rhinosinusitis. Allergol Int 2019;68:225-32. DOI:

Weitzberg E, Lundberg JO. Humming greatly increases nasal nitric oxide. Am J Respir Crit Care Med 2002;166:144-5. DOI:

Maniscalco M, Weitzberg E, Sundberg J, Sofia M, Lundberg JO. Assessment of nasal and sinus nitric oxide output using single-breath humming exhalations. Eur Respir J 2003;22:323-9. DOI:

Lundberg JO, Maniscalco M, Sofia M, Lundblad L, Weitzberg E. Humming, nitric oxide, and paranasal sinus obstruction. JAMA 2003;289:302-3. DOI:

Maniscalco M, Sofia M, Weitzberg E, De Laurentiis G, Stanziola A, Rossillo V, et al. Humming-induced release of nasal nitric oxide for assessment of sinus obstruction in allergic rhinitis: pilot study. Eur J Clin Invest 2004;34:555-60. DOI:

Shusterman DJ, Weaver EM, Goldberg AN, Schick SF, Wong HH, Balmes JR. Pilot evaluation of the nasal nitric oxide response to humming as an index of osteomeatal patency. Am J Rhinol Allergy 2012;26:123-6. DOI:

Heffler E, Marchese C, Boita M, Rolla G. Nasal nitric oxide in patients with inherited retinal dystrophies. J Investig Med 2015;63:554-7. DOI:

Brooks EA, Massanari M. Cost-effectiveness analysis of monitoring fractional exhaled nitric oxide (FeNO) in the management of asthma. Manage Care 2018;27:42-8.

Arnold RJG, Layton A, Massanari M. Cost impact of monitoring exhaled nitric oxide in asthma management. Allergy Asthma Proc 2018;39:338-44. DOI:

Sabatelli L, Seppälä U, Sastre J, Crater G. Cost-effectiveness and budget impact of routine use of fractional exhaled nitric oxide monitoring for the management of adult asthma patients in Spain. J Investig Allergol Clin Immunol 2017;27:89-97. DOI:

Kuo CR, Spears M, Haughney J, Smith A, Miller J, Bradshaw T, et al. Scottish consensus statement on the role of FeNO in adult asthma. Respir Med 2019;155:54-7. DOI:

Position Papers
Asthma diagnosis, Asthma management, Fractional Exhaled Nitric Oxide (FENO)
  • Abstract views: 4676

  • PDF: 1070
  • HTML: 9
How to Cite
Heffler, E., Carpagnano, G. E., Favero, E., Guida, G., Maniscalco, M., Motta, A., Paoletti, G., Rolla, G., Baraldi, E., Pezzella, V., Piacentini, G., & Nardini, S. G. (2020). Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC). Multidisciplinary Respiratory Medicine, 15.